Cargando…

HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy

The lung is an understudied site of HIV persistence. We isolated 898 subgenomic proviral sequences (nef) by single-genome approaches from blood and lung from nine individuals on long-term suppressive antiretroviral therapy (ART), and characterized genetic diversity and compartmentalization using for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahid, Aniqa, Jones, Bradley R., Yang, Julia S. W., Dong, Winnie, Shaipanich, Tawimas, Donohoe, Kathryn, Brumme, Chanson J., Joy, Jeffrey B., Leung, Janice M., Brumme, Zabrina L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668181/ https://www.ncbi.nlm.nih.gov/pubmed/36331974 http://dx.doi.org/10.1371/journal.ppat.1010613

Ejemplares similares

HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy
por: Omondi, F. Harrison, et al.
Publicado: (2021)

Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART
por: Brooks, Kelsie, et al.
Publicado: (2021)

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)
por: Kinloch, Natalie N., et al.
Publicado: (2021)

Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)
por: Kinloch, Natalie N., et al.
Publicado: (2021)

Evaluation of Nasopharyngeal Swab Collection Techniques for Nucleic Acid Recovery and Participant Experience: Recommendations for COVID-19 Diagnostics
por: Kinloch, Natalie N, et al.
Publicado: (2020)

Molecular Epidemiology of HIV-1 in Ghana: Subtype Distribution, Drug Resistance and Coreceptor Usage
por: Appah, Anna, et al.
Publicado: (2022)

Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort Study
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2019)

SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy
por: Cheung, Peter K., et al.
Publicado: (2023)

Concordance of HIV transmission risk factors elucidated using viral diversification rate and phylogenetic clustering
por: McLaughlin, Angela, et al.
Publicado: (2021)

HIV reservoirs are dominated by genetically younger and clonally enriched proviruses
por: Kinloch, Natalie N., et al.
Publicado: (2023)

Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected Children in Ethiopia
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2019)

Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals
por: Sakai, Keiko, et al.
Publicado: (2015)

Erratum to: Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals
por: Sakai, Keiko, et al.
Publicado: (2015)

Detection of HIV transmission hotspots in British Columbia, Canada: A novel framework for the prioritization and allocation of treatment and prevention resources
por: McLaughlin, Angela, et al.
Publicado: (2019)

Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada
por: Matic, Nancy, et al.
Publicado: (2021)

Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study
por: Sudderuddin, Hanwei, et al.
Publicado: (2020)

Phylogenetic Dependency Networks: Inferring Patterns of CTL Escape and Codon Covariation in HIV-1 Gag
por: Carlson, Jonathan M., et al.
Publicado: (2008)

Current Practice in the Management of Pulmonary Nodules Detected on Computed Tomography Chest Scans
por: Leung, Clarus, et al.
Publicado: (2019)

Inferring Human Immunodeficiency Virus 1 Proviral Integration Dates With Bayesian Inference
por: Jones, Bradley R, et al.
Publicado: (2023)

High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2018)

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada
por: Rocheleau, Genevieve, et al.
Publicado: (2017)

SARS-CoV-2 RNA Quantification Using Droplet Digital RT-PCR
por: Kinloch, Natalie N., et al.
Publicado: (2021)

T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics
por: Akahoshi, Tomohiro, et al.
Publicado: (2020)

Tracking the culprit: HIV-1 evolution and immune selection revealed by single-genome amplification
por: Brumme, Zabrina L., et al.
Publicado: (2009)

Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial
por: Li, Jonathan Z., et al.
Publicado: (2012)

Limited Evolution of Inferred HIV-1 Tropism while Viremia Is Undetectable during Standard HAART Therapy
por: Lee, Guinevere Q., et al.
Publicado: (2014)

Inhibition of the TRIM24 bromodomain reactivates latent HIV-1
por: Horvath, Riley M., et al.
Publicado: (2023)

CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells
por: Horvath, Riley M., et al.
Publicado: (2023)

Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8(+) T Cells
por: Streeck, Hendrik, et al.
Publicado: (2008)

Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy
por: Lapointe, Hope R., et al.
Publicado: (2023)

Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs
por: Brockman, Mark A., et al.
Publicado: (2015)

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
por: Brumme, Zabrina L., et al.
Publicado: (2021)

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
por: Brumme, Zabrina L., et al.
Publicado: (2022)

People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses
por: Lapointe, Hope R., et al.
Publicado: (2022)

Viral adaptation to immune selection pressure by HLA class I–restricted CTL responses targeting epitopes in HIV frameshift sequences
por: Berger, Christoph T., et al.
Publicado: (2010)

Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection
por: Shimizu, Akihisa, et al.
Publicado: (2013)

Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5
por: Jin, Steven W., et al.
Publicado: (2020)

Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity
por: Feder, Alison F, et al.
Publicado: (2021)

A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model
por: Mohan, Haneesha, et al.
Publicado: (2022)

People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses
por: Lapointe, Hope R, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r58k4u4cql2nbe2ol8gdm2f2lv